319 related articles for article (PubMed ID: 25777319)
1. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.
Miura T; Matsumoto Y; Hama T; Amano K; Tei Y; Kikuchi A; Suga A; Hisanaga T; Ishihara T; Abe M; Kaneishi K; Kawagoe S; Kuriyama T; Maeda T; Mori I; Nakajima N; Nishi T; Sakurai H; Morita T; Kinoshita H
Support Care Cancer; 2015 Nov; 23(11):3149-56. PubMed ID: 25777319
[TBL] [Abstract][Full Text] [Related]
2. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
[No Abstract] [Full Text] [Related]
3. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.
Hwang JE; Kim HN; Kim DE; Choi HJ; Jung SH; Shim HJ; Bae WK; Hwang EC; Cho SH; Chung IJ
BMC Cancer; 2011 Nov; 11():489. PubMed ID: 22103888
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Read JA; Choy ST; Beale PJ; Clarke SJ
Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings.
Amano K; Maeda I; Morita T; Miura T; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Kinoshita H
J Pain Symptom Manage; 2016 May; 51(5):860-7. PubMed ID: 26826676
[TBL] [Abstract][Full Text] [Related]
8. Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery.
Kawashima M; Murakawa T; Shinozaki T; Ichinose J; Hino H; Konoeda C; Tsuchiya T; Murayama T; Nagayama K; Nitadori J; Anraku M; Nakajima J
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):637-43. PubMed ID: 26269495
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy.
Fukuda H; Takagi T; Kondo T; Yoshida K; Shimizu S; Nagashima Y; Tanabe K
Int J Clin Oncol; 2018 Jun; 23(3):539-546. PubMed ID: 29302841
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
Leung EY; Scott HR; McMillan DC
J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
Kimura J; Kunisaki C; Makino H; Oshima T; Ota M; Oba M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
Dis Esophagus; 2016 Nov; 29(8):1071-1080. PubMed ID: 26471766
[TBL] [Abstract][Full Text] [Related]
12. Effect of continuous deep sedation on survival in patients with advanced cancer (J-Proval): a propensity score-weighted analysis of a prospective cohort study.
Maeda I; Morita T; Yamaguchi T; Inoue S; Ikenaga M; Matsumoto Y; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Tei Y; Kikuchi A; Baba M; Kinoshita H
Lancet Oncol; 2016 Jan; 17(1):115-22. PubMed ID: 26610854
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
Cao X; Yu T; Zhao G; Xiao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy.
Kunisaki C; Takahashi M; Ono HA; Oshima T; Takagawa R; Kimura J; Kosaka T; Makino H; Akiyama H; Endo I
Oncology; 2012; 83(4):183-91. PubMed ID: 22890015
[TBL] [Abstract][Full Text] [Related]
15. Development of a predicting tool for survival of terminally ill cancer patients.
Hyodo I; Morita T; Adachi I; Shima Y; Yoshizawa A; Hiraga K
Jpn J Clin Oncol; 2010 May; 40(5):442-8. PubMed ID: 20085908
[TBL] [Abstract][Full Text] [Related]
16. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
[TBL] [Abstract][Full Text] [Related]
17. The role of perioperative inflammatory-based prognostic systems in patients with colorectal liver metastases undergoing surgery. A cohort study.
Solaini L; Atmaja BT; Arumugam P; Hutchins RR; Abraham AT; Bhattacharya S; Kocher HM
Int J Surg; 2016 Dec; 36(Pt A):8-12. PubMed ID: 27742565
[TBL] [Abstract][Full Text] [Related]
18. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
[TBL] [Abstract][Full Text] [Related]
19. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
20. A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.
Yamada T; Morita T; Maeda I; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Ono S; Ozawa T; Yamamoto R; Shishido H; Yamamoto N
Cancer; 2017 Apr; 123(8):1442-1452. PubMed ID: 27926777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
